RFK Jr.’s ‘historic changes’ to drug ads would trigger range of ripple effectsnews2025-09-11T15:41:30+00:00September 11th, 2025|Endpoints News|
SEC files charges against former FibroGen CMO for manipulating clinical trial datanews2025-09-11T11:09:03+00:00September 11th, 2025|Endpoints News|
Pharma’s drug discount fight intensifies as state 340B cases reach higher courtsnews2025-09-10T18:47:44+00:00September 10th, 2025|Endpoints News|
Regeneron and Sandoz patent deal clears path for Eylea biosimilar in 2026news2025-09-09T16:33:37+00:00September 9th, 2025|Endpoints News|
J&J, Bristol Myers lose appeals cases challenging Medicare price negotiationnews2025-09-04T18:29:54+00:00September 4th, 2025|Endpoints News|
AbbVie, AstraZeneca urge judges to toss Louisiana 340B law news2025-09-03T14:25:56+00:00September 3rd, 2025|Endpoints News|
FTC and congressional oversight leader take aim at PBMs againnews2025-08-29T17:56:02+00:00August 29th, 2025|Endpoints News|
PhRMA loses fight over Oregon drug price transparency lawnews2025-08-26T19:37:40+00:00August 26th, 2025|Endpoints News|
Enanta files patent suit against Pfizer in Europenews2025-08-20T18:57:54+00:00August 20th, 2025|Endpoints News|
